XPH stock icon

SPDR S&P Pharmaceuticals ETF
XPH

$39.85
1.3%
0
Funds holding %
of 6,689 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

1% more funds holding

Funds holding: 69 [Q4 2023] → 70 (+1) [Q1 2024]

3.41% less ownership

Funds ownership: 55.14% [Q4 2023] → 51.74% (-3.41%) [Q1 2024]

6% less capital invested

Capital invested by funds: $122M [Q4 2023] → $115M (-$6.74M) [Q1 2024]

31% less call options, than puts

Call options by funds: $957K | Put options by funds: $1.38M

Research analyst outlook

We haven’t received any recent analyst ratings for XPH.

Financial journalist opinion